https://scholars.lib.ntu.edu.tw/handle/123456789/637376
標題: | Real-World Analyses of the Treatment Conditions in Patients Initiating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor in Taiwan | 作者: | Lin, Po-Lin YEN-WEN WU Lin, Chao-Feng Yeh, Hung-I Chang, Wei-Ting Charng, Min-Ji Huang, Po-Hsun Lin, Chih-Chan Lin, Tsung-Hsien Lin, Wei-Wen Hsieh, I-Chang Kuo, Feng-Yu Chen, Ching-Pei Li, Yi-Heng |
關鍵字: | Efficacy; PCSK9 inhibitor; Statin | 公開日期: | 1-九月-2023 | 卷: | 30 | 期: | 9 | 來源出版物: | Journal of atherosclerosis and thrombosis | 摘要: | Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor is a powerful low density lipoprotein cholesterol (LDL-C)-lowering therapy, but this drug is expensive. This study aimed to describe the real-world treatment conditions in patients initiating PCSK9 inhibitor in Taiwan. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/637376 | ISSN: | 13403478 | DOI: | 10.5551/jat.63789 |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。